Metastatic Liver Cancer
The liver is the largest organ inside your body, with several important functions like breaking down nutrients and removing toxic substances from blood. The symptoms of metastatic liver can be hard to identify. Hoag has the latest modalities in the accurate diagnosis of metastatic liver cancer.
What is Metastatic Liver Cancer?
Metastatic liver cancer, also known as secondary liver cancer, begins as a primary cancer in another organ outside of the liver, and eventually migrates to the liver.
In fact, the liver is the most common site (after the lymph nodes) for cancers to spread. Most of these originate from cancers of the eye, colon, rectum, pancreas, stomach, esophagus, breast, lung, melanoma and some other less common sites.
Symptoms of Metastases to the Liver
Often, secondary liver cancer does not cause symptoms during early stages. However, as the disease progresses, symptoms associated with liver disease often develop, including:
- Pain in the upper abdomen on the right side; the pain may extend to the back and shoulder
- Swollen abdomen (bloating)
- Weight loss, loss of appetite and/or feelings of fullness
- Weakness and/or fatigue
- Nausea and vomiting
- Yellow skin and eyes, and dark urine from jaundice
If you’re experiencing any of these symptoms, it’s important to seek proper evaluation and treatment from a healthcare expert experienced in the diagnosis and liver cancer treatment options.
Liver Cancer Nurse Navigator
A clinical nurse navigator serves an important role as facilitator and guide for patients, providing resources, access to clinical providers and answering questions throughout the cancer journey.
Risk Factors for Metastases to the Liver
Most cancers can metastasise to the liver. The following primary cancer sites are those most likely to cause liver metastases:
Liver Treatment Expertise You Can Trust!
Hoag’s committed to accurate diagnosis, combined with progressive therapeutic options enables Hoag patients to achieve some of the highest clinical outcomes in the nation.